| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.86B | 26.69B | 24.22B | 18.54B | 13.57B | 7.34B |
| Gross Profit | 8.69B | 9.53B | 7.46B | 5.78B | 4.17B | 3.02B |
| EBITDA | 3.05B | 3.84B | 2.51B | 2.03B | 1.57B | 1.26B |
| Net Income | 1.18B | 1.70B | 1.39B | 1.15B | 892.41M | 667.02M |
Balance Sheet | ||||||
| Total Assets | 32.95B | 30.47B | 24.02B | 21.96B | 23.02B | 12.34B |
| Cash, Cash Equivalents and Short-Term Investments | 7.89B | 7.67B | 4.66B | 5.23B | 3.65B | 3.47B |
| Total Debt | 15.90B | 12.13B | 8.42B | 8.67B | 11.64B | 3.19B |
| Total Liabilities | 18.83B | 16.12B | 11.56B | 10.64B | 13.22B | 4.46B |
| Stockholders Equity | 13.53B | 13.78B | 12.27B | 11.09B | 9.80B | 7.88B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 185.31M | 73.83M | 3.78B | -8.16B | -3.82B |
| Operating Cash Flow | 0.00 | 435.30M | 452.64M | 4.36B | -7.31B | -3.57B |
| Investing Cash Flow | 0.00 | -1.37B | -376.36M | -427.07M | -1.64B | -253.80M |
| Financing Cash Flow | 0.00 | 1.94B | -554.26M | -3.13B | 9.31B | 3.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥12.01B | 11.85 | ― | 4.98% | 3.29% | -1.74% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | ¥41.20B | 9.84 | ― | 0.45% | -8.33% | -36.89% | |
62 Neutral | ¥68.70B | 8.53 | ― | 2.89% | -3.09% | -35.66% | |
60 Neutral | ¥66.85B | 9.58 | ― | 5.71% | 8.07% | 12.06% | |
59 Neutral | ¥13.53B | 6.93 | ― | 1.47% | 20.82% | 9.86% | |
56 Neutral | ¥16.47B | 5.83 | ― | ― | 23.19% | 44.46% |